Favourable outcome of coronavirus disease 2019 in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer receiving alectinib.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)109-112
Number of pages4
JournalEur. J. Cancer
Volume138
DOIs
Publication statusPublished - Aug 11 2020

Keywords

  • Aged
  • Anaplastic Lymphoma Kinase/antagonists & inhibitors
  • Anti-HIV Agents/therapeutic use
  • Betacoronavirus/isolation & purification
  • COVID-19
  • Carbazoles/pharmacology
  • Carcinoma, Non-Small-Cell Lung/complications
  • Coronavirus Infections/complications
  • Drug Combinations
  • Humans
  • Hydroxychloroquine/therapeutic use
  • Lopinavir/therapeutic use
  • Lung/diagnostic imaging
  • Lung Neoplasms/complications
  • Male
  • Masks
  • Noninvasive Ventilation/instrumentation
  • Pandemics
  • Piperidines/pharmacology
  • Pneumonia, Viral/complications
  • Ritonavir/therapeutic use
  • SARS-CoV-2
  • Tomography, X-Ray Computed
  • Treatment Outcome

Cite this